Laboratorios Del Dr Esteve SA - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Summary

Laboratorios Del Dr Esteve SA (Esteve) researches, develops and markets prescription and generic pharmaceutical products. The companys product portfolio encompasses innovative prescription drugs, over-the-counter (OTC) pharmaceuticals and generic drugs. It offers drugs in central nervous system, infection, respiratory, cardiovascular, cancer, primary care and other therapeutic areas. Esteve also develops, manufactures and markets active pharmaceutical ingredients (APIs) and advanced intermediates for the global pharmaceutical industry. The company markets its products to pharmaceutical companies, healthcare facilities, and other customers through licensing agreements and distributors. It operates subsidiaries and production centers in Europe, America and Asia. Esteve is headquartered in Barcelona, Spain.

Laboratorios Del Dr Esteve SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 5
List of Figures 5
Laboratorios Del Dr Esteve SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Laboratorios Del Dr Esteve SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Laboratorios Del Dr Esteve SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Laboratorios Del Dr Esteve SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Laboratorios Del Dr Esteve SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Laboratorios Del Dr Esteve SA, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Breckenridge Pharma Acquires Five ANDAs from Nostrum Lab 12
Breckenridge Pharma Acquires ANDA from Impopharma 13
Breckenridge Pharma Completes Acquisition of Certain Generic Assets From Pernix Therapeutics For US$30 Million 14
Partnerships 16
Mundipharma Medical and Purdue Pharma Enter into Licensing Agreement with Esteve 16
Breckenridge Pharma Enters into Agreement with Sam Chun Dang Pharm 17
Breckenridge Pharma Enters into Marketing Agreement with Gland Pharma 18
Esteve Enters into Agreement with AstraZeneca 19
Eisai Enters into Agreement with Esteve 20
Enzymatica Enters into Distribution Agreement with Esteve 21
Mundipharma and Purdue Pharma Enter into Development Agreement with Esteve 22
Breckenridge Pharma Enters into Co-Marketing Agreement with MSN Labs for ANDAs 23
Breckenridge Pharma Enters into Co-Development Agreement with Pharmaceutics International 24
SEFAC and Esteve Forms partnership 25
Eisai Enters into Co-Marketing Agreement with Esteve for Zonegran 26
Breckenridge Pharma Enters Into Co-Development Agreement With Welding And SK Chemicals 27
Breckenridge Pharma Enters Into Co-Marketing Agreement With Aptalis Pharmatech For Inderal LA 28
Breckenridge Pharma Enters Into Co-Marketing Agreement With Marksans Pharma For Gabapentin Capsules 29
Breckenridge Pharma Enters Into Co-Marketing Agreement With Ajanta Pharma For Risperdal Tablet 30
Pamlab Enters Into Joint Venture With Breckenridge To Distribute Medical Food Products 31
Breckenridge Pharma Enters Into Co-Marketing Agreement With Zhejiang Huahai Pharma For Nevirapine 32
Licensing Agreements 33
ReGenX Biosciences Enters Into Licensing Agreement With Esteve 33
Asset Transactions 34
Ecuphar Acquires Veterinary Division from Esteve 34
Laboratorios Del Dr Esteve SA - Key Competitors 35
Laboratorios Del Dr Esteve SA - Key Employees 36
Laboratorios Del Dr Esteve SA - Locations And Subsidiaries 37
Head Office 37
Other Locations & Subsidiaries 37
Joint Venture 39
Recent Developments 40
Government and Public Interest 40
Oct 23, 2017: Researchers prove the effectiveness of a new drug to prevent the onset and the pain of chemotherapy-induced neuropathy 40
Other Significant Developments 41
Mar 19, 2018: Pensa Pharma Renews its Corporate Website and Launches Local Websites 41
Appendix 42
Methodology 42
About GlobalData 42
Contact Us 42
Disclaimer 42

List Of Tables

List of Tables
Laboratorios Del Dr Esteve SA, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Laboratorios Del Dr Esteve SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Laboratorios Del Dr Esteve SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Laboratorios Del Dr Esteve SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Laboratorios Del Dr Esteve SA, Deals By Therapy Area, 2012 to YTD 2018 9
Laboratorios Del Dr Esteve SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Breckenridge Pharma Acquires Five ANDAs from Nostrum Lab 12
Breckenridge Pharma Acquires ANDA from Impopharma 13
Breckenridge Pharma Completes Acquisition of Certain Generic Assets From Pernix Therapeutics For US$30 Million 14
Mundipharma Medical and Purdue Pharma Enter into Licensing Agreement with Esteve 16
Breckenridge Pharma Enters into Agreement with Sam Chun Dang Pharm 17
Breckenridge Pharma Enters into Marketing Agreement with Gland Pharma 18
Esteve Enters into Agreement with AstraZeneca 19
Eisai Enters into Agreement with Esteve 20
Enzymatica Enters into Distribution Agreement with Esteve 21
Mundipharma and Purdue Pharma Enter into Development Agreement with Esteve 22
Breckenridge Pharma Enters into Co-Marketing Agreement with MSN Labs for ANDAs 23
Breckenridge Pharma Enters into Co-Development Agreement with Pharmaceutics International 24
SEFAC and Esteve Forms partnership 25
Eisai Enters into Co-Marketing Agreement with Esteve for Zonegran 26
Breckenridge Pharma Enters Into Co-Development Agreement With Welding And SK Chemicals 27
Breckenridge Pharma Enters Into Co-Marketing Agreement With Aptalis Pharmatech For Inderal LA 28
Breckenridge Pharma Enters Into Co-Marketing Agreement With Marksans Pharma For Gabapentin Capsules 29
Breckenridge Pharma Enters Into Co-Marketing Agreement With Ajanta Pharma For Risperdal Tablet 30
Pamlab Enters Into Joint Venture With Breckenridge To Distribute Medical Food Products 31
Breckenridge Pharma Enters Into Co-Marketing Agreement With Zhejiang Huahai Pharma For Nevirapine 32
ReGenX Biosciences Enters Into Licensing Agreement With Esteve 33
Ecuphar Acquires Veterinary Division from Esteve 34
Laboratorios Del Dr Esteve SA, Key Competitors 35
Laboratorios Del Dr Esteve SA, Key Employees 36
Laboratorios Del Dr Esteve SA, Other Locations 37
Laboratorios Del Dr Esteve SA, Subsidiaries 37
Laboratorios Del Dr Esteve SA, Joint Venture 39

List Of Figures

List of Figures
Laboratorios Del Dr Esteve SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Laboratorios Del Dr Esteve SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Laboratorios Del Dr Esteve SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Laboratorios Del Dr Esteve SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Laboratorios Del Dr Esteve SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Laboratorios Del Dr Esteve SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Laboratorios Del Dr Esteve SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Laboratorios Del Dr Esteve SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Laboratorios Del Dr Esteve SA - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Laboratorios Del Dr Esteve SA (Esteve) researches, develops and markets prescription and generic pharmaceutical products. The companys product portfolio encompasses innovative prescription drugs, over-the-counter (OTC) pharmaceuticals and generic drugs. It

USD 250 View Report

Laboratorios Del Dr Esteve SA Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

Laboratorios Del Dr Esteve SA Company Profile is a detailed strategic and analytical report on Laboratorios Del Dr Esteve SA. The 2018 version of the report offers detailed insights into

USD 200 View Report

Laboratorios Del Dr Esteve SA Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

Laboratorios Del Dr Esteve SA Company Profile is a detailed strategic and analytical report on Laboratorios Del Dr Esteve SA. The 2018 version of the report offers detailed insights into

USD 200 View Report

Laboratorios Del Dr Esteve SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Laboratorios Del Dr Esteve SA (Esteve) researches, develops and markets prescription and generic pharmaceutical products. The companys product portfolio encompasses innovative prescription drugs, over-the-counter (OTC) pharmaceuticals and generic drugs. It

USD 250 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available